Generation of a Jurkat-based fluorescent reporter cell line to evaluate lipid antigen interaction with the human iNKT cell receptor.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
15 05 2019
15 05 2019
Historique:
received:
04
03
2019
accepted:
23
04
2019
entrez:
17
5
2019
pubmed:
17
5
2019
medline:
27
10
2020
Statut:
epublish
Résumé
Invariant natural killer T (iNKT) cells are a specialized subset of T cells contributing to both, the innate and adaptive immune responses. In contrast to conventional T lymphocytes they recognize lipid antigens. The aim of the project is to establish a novel model system, to study iNKT-TCR - ligand interaction. An iNKT reporter cell line (JE6-1
Identifiants
pubmed: 31092850
doi: 10.1038/s41598-019-43529-4
pii: 10.1038/s41598-019-43529-4
pmc: PMC6520406
doi:
Substances chimiques
Antigens
0
Lipids
0
Receptors, Natural Killer Cell
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
7426Commentaires et corrections
Type : ErratumIn
Références
Oncol Rep. 2011 Mar;25(3):831-40
pubmed: 21206981
N Engl J Med. 2006 Mar 16;354(11):1117-29
pubmed: 16540612
J Immunol Methods. 2010 Oct 31;362(1-2):131-41
pubmed: 20858499
J Immunol. 2009 Feb 15;182(4):2492-501
pubmed: 19201905
Clin Exp Allergy. 2017 Nov;47(11):1398-1408
pubmed: 28618148
J Am Chem Soc. 2008 Sep 17;130(37):12348-54
pubmed: 18712867
Microbes Infect. 2007 Mar;9(3):364-74
pubmed: 17314060
Proc Natl Acad Sci U S A. 2012 May 8;109(19):E1143-52
pubmed: 22493234
Nature. 2001 Oct 4;413(6855):531-4
pubmed: 11586362
J Immunol. 1998 Oct 1;161(7):3271-81
pubmed: 9759842
Nat Med. 2002 Jun;8(6):588-93
pubmed: 12042809
J Exp Med. 2007 May 14;204(5):1131-44
pubmed: 17485514
J Exp Med. 1994 Sep 1;180(3):1171-6
pubmed: 8064234
Science. 1997 Nov 28;278(5343):1626-9
pubmed: 9374463
Eur J Immunol. 2006 Oct;36(10):2595-600
pubmed: 16981180
Arch Immunol Ther Exp (Warsz). 2016 Aug;64(4):291-8
pubmed: 26703211
Science. 2014 Jan 3;343(6166):84-87
pubmed: 24336571
Nat Rev Immunol. 2012 Dec;12(12):845-57
pubmed: 23154222
Science. 1994 Mar 25;263(5154):1774-8
pubmed: 7907820
Clin Exp Allergy. 2014 Jan;44(1):58-68
pubmed: 24118614
Immunity. 2012 Sep 21;37(3):574-87
pubmed: 22981538
Nature. 1987 Sep 17-23;329(6136):251-4
pubmed: 3114646
J Immunol. 1999 Jun 1;162(11):6410-9
pubmed: 10352254
Allergy. 2013 Jan;68(1):74-83
pubmed: 23137012
J Immunol Methods. 2016 Mar;430:10-20
pubmed: 26780292
Annu Rev Immunol. 2007;25:297-336
pubmed: 17150027
Proc Natl Acad Sci U S A. 2010 Jul 20;107(29):13010-5
pubmed: 20616071
Cancer Res. 2012 Aug 1;72(15):3744-52
pubmed: 22649190
J Clin Exp Hematop. 2007 Apr;47(1):1-8
pubmed: 17510531
J Vis Exp. 2012 Dec 29;(70):
pubmed: 23299308
Adv Cancer Res. 2008;101:277-348
pubmed: 19055947
Nucleic Acids Res. 2018 Jun 1;46(10):e58
pubmed: 29538768
Int Immunol. 1989;1(6):557-64
pubmed: 2562245
Nat Rev Immunol. 2018 Sep;18(9):559-574
pubmed: 29967365
Nat Immunol. 2016 Jun;17(6):728-39
pubmed: 27089380
J Immunol. 1989 Sep 15;143(6):1822-5
pubmed: 2778316
Nat Methods. 2014 Aug;11(8):783-784
pubmed: 25075903
Sci Rep. 2016 Aug 19;6:31580
pubmed: 27539532
Oncotarget. 2017 May 4;8(39):64892-64906
pubmed: 29029399
J Biol Chem. 2012 Mar 16;287(12):8816-29
pubmed: 22294696
Toxicol In Vitro. 2015 Sep;29(6):1275-82
pubmed: 25448806
Nat Immunol. 2011 Sep 04;12(10):966-74
pubmed: 21892173
J Clin Invest. 2002 Sep;110(6):793-800
pubmed: 12235110
J Med Chem. 1995 Jun 9;38(12):2176-87
pubmed: 7783149
J Exp Med. 1994 Sep 1;180(3):1097-106
pubmed: 7520467
Immunity. 2009 Jul 17;31(1):47-59
pubmed: 19592275
Eur J Immunol. 2016 May;46(5):1224-34
pubmed: 26873393
Clin Cancer Res. 2006 Oct 15;12(20 Pt 1):6079-86
pubmed: 17028247
Cancer Immunol Res. 2015 May;3(5):425-35
pubmed: 25941354
J Immunol. 1997 Sep 1;159(5):2240-9
pubmed: 9278312